Moleculin Reports Third Quarter 2023 Financial Results

Go back to Moleculin Reports Third Quarter 2023 Financial Results
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 0.52 +0.07 (15.56%)
Previous Close $0.45    52 Week High $9.58 
Open $0.45    52 Week Low $2.34 
Day High $0.53    P/E N/A 
Day Low $0.43    EPS $-0.34 
Volume 1,271,163